Britons with heart failure are being given larger doses of drugs at the start of their treatment after a global trial found ...

The New Jersey-based company's shares fell 1.6% in extended trading. The drug, mavacamten, was tested in adult patients with ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

As thousands of people await a lifesaving heart, scientists are racing to buy them more time. A promising advance from scientists in Germany offers a potential solution.

Hydrogels, which are soft materials formed by cross-linking polymers, could have a variety of medical applications. In ...

Finerenone prevented new-onset atrial fibrillation or flutter in patients with chronic kidney disease and type 2 diabetes or ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

A retrospective analysis from Israel suggested that markers of poor hydration are linked to increased risks of hypertension ...

A team of scientists led by Northwestern Medicine investigators have uncovered new details about a deadly heart condition with limited treatment options, according to a study published in the journal ...

Use of routine thoracentesis in addition to medical therapy yielded no significant benefits for adults with heart failure and pleural effusions, according to a new study.